Joseph V. Schlosser

550 total citations
25 papers, 397 citations indexed

About

Joseph V. Schlosser is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph V. Schlosser has authored 25 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph V. Schlosser's work include Estrogen and related hormone effects (9 papers), Breast Cancer Treatment Studies (5 papers) and Ocular Oncology and Treatments (4 papers). Joseph V. Schlosser is often cited by papers focused on Estrogen and related hormone effects (9 papers), Breast Cancer Treatment Studies (5 papers) and Ocular Oncology and Treatments (4 papers). Joseph V. Schlosser collaborates with scholars based in United States and France. Joseph V. Schlosser's co-authors include Albert Segaloff, Benjamin N. Horwitt, Douglas Gordon, R. Anthony Carabasi, Luciano Debéljuk, Tsuyoshi Karashima, Andrew V. Schally, Matthew G. Sampson, C. Y. Bowers and Abe Mickal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and Radiology.

In The Last Decade

Joseph V. Schlosser

25 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph V. Schlosser United States 12 120 113 102 82 56 25 397
R. Hertz United States 9 30 0.3× 76 0.7× 54 0.5× 77 0.9× 29 0.5× 25 540
Richard S. Bornstein United States 10 37 0.3× 126 1.1× 26 0.3× 88 1.1× 14 0.3× 11 380
J. D. Fergusson United Kingdom 13 44 0.4× 63 0.6× 322 3.2× 76 0.9× 32 0.6× 31 542
Winston Ueno United States 8 59 0.5× 265 2.3× 113 1.1× 39 0.5× 78 1.4× 13 531
D. B. Thomson Australia 7 80 0.7× 72 0.6× 32 0.3× 46 0.6× 45 0.8× 13 302
Ratna Paul Finland 9 38 0.3× 50 0.4× 58 0.6× 34 0.4× 24 0.4× 26 330
Russell Hogg Australia 11 71 0.6× 90 0.8× 37 0.4× 64 0.8× 234 4.2× 14 448
Geoffrey Otton Australia 12 77 0.6× 114 1.0× 38 0.4× 108 1.3× 84 1.5× 20 397
H. S. Levin United States 9 74 0.6× 84 0.7× 181 1.8× 133 1.6× 8 0.1× 15 396
A. Costantini Italy 11 53 0.4× 24 0.2× 271 2.7× 195 2.4× 36 0.6× 24 443

Countries citing papers authored by Joseph V. Schlosser

Since Specialization
Citations

This map shows the geographic impact of Joseph V. Schlosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph V. Schlosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph V. Schlosser more than expected).

Fields of papers citing papers by Joseph V. Schlosser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph V. Schlosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph V. Schlosser. The network helps show where Joseph V. Schlosser may publish in the future.

Co-authorship network of co-authors of Joseph V. Schlosser

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph V. Schlosser. A scholar is included among the top collaborators of Joseph V. Schlosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph V. Schlosser. Joseph V. Schlosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schally, Andrew V., et al.. (1987). Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.. Proceedings of the National Academy of Sciences. 84(3). 851–855. 65 indexed citations
3.
Mira, Joaquin G., Robert B. Livingston, Terence N. Moore, et al.. (1982). Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma. A Southwest oncology group study. Cancer. 50(7). 1266–1272. 28 indexed citations
4.
Lyons, George D., et al.. (1978). Laser surgery and immunotherapy in the management of laryngeal papilloma. The Laryngoscope. 88(10). 1586–1588. 19 indexed citations
5.
Mickal, Abe, José E. Torres, & Joseph V. Schlosser. (1972). Complications of therapy for carcinoma of the cervix. American Journal of Obstetrics and Gynecology. 112(4). 556–565. 15 indexed citations
6.
Schlegel, J.U., et al.. (1967). Effect of Irradiation on Renal Function. The Journal of Urology. 97(1). 36–39. 9 indexed citations
7.
Krementz, Edward T., et al.. (1966). COMBINED RADIATION AND REGIONAL CHEMOTHERAPY IN THE TREATMENT OF RETINOBLASTOMA. American Journal of Roentgenology. 96(1). 141–146. 4 indexed citations
8.
Schlegel, J.U., et al.. (1966). Function Changes Secondary to Local Irradiation in Kidneys Damaged by Ischemia. The Journal of Urology. 96(1). 16–19. 2 indexed citations
9.
Schlosser, Joseph V., et al.. (1966). Control of peritoneal implantation by postoperative irradiation.. PubMed. 25(3). 308–12. 1 indexed citations
10.
Krementz, Edward T., et al.. (1964). RETINOBLASTOMA: BEHAVIOR AND TREATMENT WITH FRACTIONAL IRRADIATION AND INTRA‐ARTERIAL TRIETHYLENEMELAMINE*. Annals of the New York Academy of Sciences. 114(2). 963–975. 7 indexed citations
11.
Krementz, Edward T., et al.. (1963). Treatment of Retinoblastoma by Fractional Intra-Arterial T.E.M. and X-Ray Therapy. Southern Medical Journal. 56(9). 1023–1025. 5 indexed citations
13.
Segaloff, Albert, et al.. (1957). Hormonal therapy in cancer of the breastXII. The effect of etiocholanolone therapy on clinical course and hormonal excretion. Cancer. 10(6). 1116–1118. 15 indexed citations
14.
Segaloff, Albert, et al.. (1957). Hormonal therapy in cancer of the breastXI. The effect of dehydroepiandrosterone on clinical course and hormonal excretion. Cancer. 10(6). 1114–1115. 2 indexed citations
15.
16.
Segaloff, Albert, et al.. (1954). Hormonal therapy in cancer of the breast.VI. Effect of ACTH and cortisone on clinical course and hormonal excretion. Cancer. 7(2). 331–334. 29 indexed citations
17.
18.
Segaloff, Albert, et al.. (1953). Hormonal therapy in cancer of the breast. V. The effect of methyltestosterone on clinical course and hormonal excretion. Cancer. 6(3). 483–487. 20 indexed citations
19.
Gordon, Douglas, et al.. (1952). Hormonal therapy in cancer of the breast.III. Effect of progesterone on clinical course and hormonal excretion. Cancer. 5(2). 275–277. 25 indexed citations
20.
Segaloff, Albert, et al.. (1952). Hormonal therapy in cancer of the breast.IV. Effect of androstenediol on clinical course and hormonal excretion. Cancer. 5(6). 1179–1181. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026